Garry E. Menzel, Director of Black Diamond Therapeutics BDTX, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/26.

GM

GM

Garry E. Menzel

Director

Company

Black Diamond Therapeutics BDTX

First filing

23/05/17

Trades

31 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

06/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Adaptimmune TherapeuticsADAPY	Open-market sale	23/07/10	23/07/10	47,702 sh	$0.91	$43,408.82	−38.9%